SREBF1 and fatty liver disease: In non-alcoholic hepatic steatosis, baicalin improves high-fat diet-induced MAFLD by inhibiting SREBP1 and NF-κB signaling pathways via AMPK-mediated mechanisms and activating the Nrf2 signaling pathway (Gao et al., 2023).